Are Investors Undervaluing Baxter International (BAX) Right Now?
Alpha Vantage · Yahoo Finance · · AI-summarised by FinFlash
Zacks Equity Research suggests that Baxter International (BAX) and Zimmer Biomet (ZBH) appear to be undervalued based on various financial metrics. Both companies currently hold a Zacks Rank #2 (Buy) and an "A" grade for Value, with BAX showing attractive P/E, PEG, P/B, and P/S ratios compared to its industry averages. The article highlights these metrics as indicators for value investors to consider.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.